Robert Jeffrey Aukema, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocannabinoids | 7 | 2023 | 111 | 1.860 |
Why?
|
| Arachidonic Acids | 3 | 2023 | 294 | 1.160 |
Why?
|
| Polyunsaturated Alkamides | 3 | 2023 | 29 | 1.110 |
Why?
|
| Amygdala | 1 | 2023 | 1354 | 0.510 |
Why?
|
| Stress, Psychological | 2 | 2024 | 4481 | 0.370 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2021 | 137 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 586 | 0.190 |
Why?
|
| Rats | 5 | 2024 | 23742 | 0.190 |
Why?
|
| Fear | 2 | 2018 | 1476 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 598 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2024 | 8181 | 0.170 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2023 | 701 | 0.160 |
Why?
|
| Cannabinoids | 1 | 2021 | 172 | 0.160 |
Why?
|
| Amidohydrolases | 3 | 2023 | 159 | 0.120 |
Why?
|
| Anxiety | 2 | 2021 | 4573 | 0.120 |
Why?
|
| Neural Inhibition | 1 | 2018 | 590 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2023 | 2161 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2023 | 2219 | 0.110 |
Why?
|
| Placenta | 1 | 2021 | 1709 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2639 | 0.090 |
Why?
|
| Animals | 10 | 2024 | 168459 | 0.090 |
Why?
|
| Corticosterone | 2 | 2023 | 305 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 1436 | 0.090 |
Why?
|
| Memory | 1 | 2018 | 2188 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 2151 | 0.070 |
Why?
|
| Hippocampus | 1 | 2018 | 3766 | 0.060 |
Why?
|
| Extinction, Psychological | 2 | 2018 | 371 | 0.060 |
Why?
|
| Neurons | 1 | 2024 | 9463 | 0.060 |
Why?
|
| Drug Inverse Agonism | 1 | 2023 | 11 | 0.060 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2023 | 114 | 0.050 |
Why?
|
| Agouti-Related Protein | 1 | 2023 | 93 | 0.050 |
Why?
|
| Behavior, Animal | 2 | 2021 | 1878 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2023 | 361 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2021 | 413 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 4575 | 0.040 |
Why?
|
| Male | 6 | 2024 | 360804 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2023 | 552 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2018 | 60 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 1157 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2023 | 999 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 290 | 0.040 |
Why?
|
| Protective Agents | 1 | 2018 | 150 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2018 | 336 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2018 | 261 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2018 | 182 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 1141 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 1173 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2206 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4124 | 0.020 |
Why?
|
| Pregnancy | 2 | 2021 | 29874 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2018 | 4217 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 81525 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 88319 | 0.010 |
Why?
|
| Female | 4 | 2021 | 392644 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18252 | 0.010 |
Why?
|
| Humans | 4 | 2023 | 761504 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59243 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 221177 | 0.000 |
Why?
|